Elevated GFAP levels were positively associated with a greater psychiatric symptom burden, specifically anxiety/depression scores, a finding that is congruent with previous reports of elevated GFAP levels in CSF in patients with major depression [56]. The gene discussed is GFAP; the disease is depressive symptom measurement.